Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.23
+0.03 (0.27%)
Jun 6, 2025, 4:00 PM - Market closed
Roivant Sciences Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Roivant Sciences stock ranges from a low of $12.5 to a high of $22. The average analyst price target of $17.5 forecasts a 55.83% increase in the stock price over the next year.
Price Target: $17.50 (+55.83%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Roivant Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 1 | 1 |
| Buy | 4 | 4 | 3 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 8 | 8 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +60.28% | May 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +60.28% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +60.28% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +60.28% | Nov 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 19, 2024 |
Financial Forecast
Revenue This Year
28.91M
from 29.05M
Decreased by -0.49%
Revenue Next Year
159.19M
from 28.91M
Increased by 450.60%
EPS This Year
-1.28
from -0.24
EPS Next Year
-1.46
from -1.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 63.0M | 627.3M | 1.2B | ||
| Avg | 28.9M | 159.2M | 515.7M | ||
| Low | 7.0M | 23.5M | 54.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 116.8% | 2,069.6% | 684.0% | ||
| Avg | -0.5% | 450.6% | 224.0% | ||
| Low | -76.0% | -18.6% | -65.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.08 | -1.22 | 0.01 | ||
| Avg | -1.28 | -1.46 | -0.63 | ||
| Low | -1.43 | -1.83 | -0.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.